Tapemark

Click below for the latest Tapemark Press Release Tapemark Announces Organizational Changes in Sales Tapemark Signs Snap!® License Agreement Tapemark Plans for the Future; Names New CEO and President/COO CONTRACT MANUFACTURING OF PRESSURE SENSITIVE ADHESIVE COMPONENTS The Tapemark Company is a privately held full-service contract manufacturer with multiple facilities in West St. Paul, Minnesota. Throughout its 50-year history, Tapemark has been a leader in innovative technologies that address unique customer needs. Tapemark’s integrated converting capabilities include coating, printing, die cutting and packaging of complex components and products for the medical, pharmaceutical, and consumer products markets. Tapemark’s strategic focus is on utilizing advanced technologies coupled with long-term development and service partnerships with customers and vendors. Tapemark’s capabilities include coating, printing, rotary and reciprocating die cutting, laminating, slitting, custom sterilizable packaging, and Chipless ID. www.tapemark.com/d_dc.htm As a leading converter to the Medical Device industry, Tapemark maintains multiple clean rooms with pressure, particulate and temperature/humidity monitoring controls, and adjacent white rooms for packaging. Tapemark also offers onsite microbial and chemistry laboratories. www.tapemark.com/d_med.htm Tapemark’s Chipless ID is an RFID implementation for brand protection, anti-counterfeiting, and protection of revenue from consumables, important factors within the medical device industry. Chipless ID uses an inexpensive RFID tag with microscopic antennas complemented with an application-specific reader. Tapemark follows cGMP and is ISO 9001 and ISO 13485 registered. In addition, Tapemark is proud to be registered as a contract manufacturer with the FDA for Device, Drug, and Food. Tapemark is experienced with sourcing pressure sensitive adhesives films, foils and double and single coated foams, as well as conductive adhesives, hydrogels and hydrocolloids. Our complete Technical Development functions include prototyping, short clinical evaluation runs, Design of Experiment (DOE), Process Validation and First Article capabilities to support customers throughout the design and regulatory approval phases and into full production. www.tapemark.com/d_qs.htm Tapemark has developed a "product line" that maximizes their regulatory and quality value and meets a growing market need. The product line includes soluble film, single use pad, hydrogel and transdermal systems for delivering a wide range of active ingredients and drug types. These systems open up possibilities for customers to re-introduce established brands in new ways and thereby capture additional market share and consumer loyalty. For example, the innovative marriage of coating and converting technologies has opened the door to new market opportunities for products that deliver active ingredients in convenient, single use formats. An "active," such as a drug, vitamin, antiseptic or flavor, is combined with an appropriate hydrogel or water-soluble film. Both are available with specific properties to ensure compatibility. Some gels and films are highly attracted to water-based actives. Others have absorptive properties and can pull exudates from the skin equaling up to seven times their weight in water. Gels and films also have the ability to slowly release the active through passive diffusion, making the end product effective over an extended period of time. Available testing methodology confirms that the active is delivered at the required concentration, rate and composition. One step through an integrated die cutting press produces a single use patch, swatch or dressing. In-line web handling technology can precisely cut, stack and place the finished product in customized, hermetic packaging as needed. Tapemark has specialized in innovative converting for fifty years from its West St. Paul, Minnesota campus. Sales offices are located throughout the United States. www.tapemark.com/d_about.htm